Martin Madaus

Martin Madaus

Chairman bei QUANTERIX CORPORATION

Vermögen: 7 Mio $ am 31.03.2024

64 Jahre
Health Technology
Commercial Services
Health Services

Profil

Martin D.
Madaus
is currently serving as the Chairman at Quanterix Corp.
since 2022 and as the Executive Chairman at Emulate, Inc. since 2020.
He is also a Director at Candela Corp., Repligen Corp., Azenta, Inc., Massachusetts High Technology Council, Inc., Unchained Labs, Ultivue, Inc., Candela Medical, Inc., Syntis Bio, Inc., Unchained Labs LLC, and Sherlock Biosciences, Inc. Additionally, Dr. Madaus has held former positions as the Chairman, President & Chief Executive Officer at EMD Millipore Corp.
from 2005 to 2010, Chairman & Chief Executive Officer at Ortho-Clinical Diagnostics, Inc. from 2014 to 2019, President & Chief Executive Officer at Roche Diagnostics Corp.
from 2000 to 2004, Chairman, President & Chief Executive Officer at Millipore SA from 2005 to 2010, and Vice President-Business Development at Roche Molecular Systems, Inc. He has also served as a Director at Pharmaceutical Product Development LLC, Mettler-Toledo International, Inc., Standard BioTools, Inc., Covidien Unlimited Co., New England Healthcare Institute, Massachusetts Technology Collaborative, Predictive Biosciences, Inc., Young Men's Christian Association of Greater Boston, Inc., and Analytical Life Science & Diagnostics Association.
Dr. Madaus holds a doctorate degree from Ludwig-Maximilians-Universität München and The University of Veterinary Medicine Hanover.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
02.01.2024 276 023 ( 0,73% ) 7 Mio $ 31.03.2024
18.03.2024 2 308 ( 0,00% ) 424 487 $ 31.03.2024
20.10.2023 104 111 ( 0,04% ) 282 141 $ 31.03.2024
12.02.2024 2 465 ( 0,00% ) 148 590 $ 31.03.2024

Aktive Positionen von Martin Madaus

UnternehmenPositionBeginn
QUANTERIX CORPORATION Chairman 08.08.2022
CANDELA MEDICAL, INC. Director/Board Member 01.05.2018
REPLIGEN CORPORATION Director/Board Member 06.02.2023
AZENTA, INC. Director/Board Member 30.01.2024
Director/Board Member -
Director/Board Member -
Director/Board Member 01.07.2021
Director/Board Member 01.07.2021
Chief Operating Officer 09.09.2020
░░░░░░░ ░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Alle aktiven Positionen von Martin Madaus

Ehemalige bekannte Positionen von Martin Madaus

UnternehmenPositionEnde
░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Martin Madaus im Detail an

Ausbildung von Martin Madaus

Ludwig-Maximilians-Universität München Doctorate Degree
The University of Veterinary Medicine Hanover Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Martin Madaus im Detail an

Beziehungen

99

Beziehungen ersten Grades

30

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
REPLIGEN CORPORATION

Health Technology

AZENTA, INC.

Health Services

METTLER-TOLEDO INTERNATIONAL, INC.

Health Technology

STANDARD BIOTOOLS INC.

Health Technology

QUANTERIX CORPORATION

Health Technology

Private Unternehmen23

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Technology Services

Health Technology

Commercial Services

Health Services

Commercial Services

Health Services

Commercial Services

Electronic Technology

Boehringer Mannheim Corp. (California)

Analytical Life Science & Diagnostics Association

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Martin Madaus